Delivery Order SPE2DB25D3306-SPE2DB26FUANH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units) with a ceiling value of $1,659.37. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $21,113.12 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections with a ceiling value of $5,141.16. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is set for completion by September 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,706.08 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 20, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a $7,509.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on August 19, 2025, with ultimate completion scheduled for August 20, 2025. This competitive award, placed under no set-aside designation, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement...
- The Defense Logistics Agency awarded a $13,125.18 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed-price contract, which is a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. The award was made through open competition...
- The Defense Logistics Agency awarded a delivery order valued at $10,167.94 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 11, 2025, with completion targeted for August 12, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's broader pharmaceutical supply arrangement with the federal government. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,188.64 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $3,812.90. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and represents a non-competitive set-aside contract. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $26,707.66 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUANHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,206.82 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections on October 27, 2025. This firm fixed-price delivery order, which is part of a larger indefinite delivery contract, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. Zepbound is a glucagon-like peptide-1 receptor agonist used in diabetes and weight management treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military healthcare systems. This delivery order is issued under AmerisourceBergen's existing $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. As a child contract under this prime indefinite delivery vehicle, this order enables AmerisourceBergen to supply critical pharmaceutical products to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to meet federal medical procurement requirements through open competition and competitive pricing mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 10/27/25 |